Literature DB >> 2349923

Oral copper supplementation: effect on copper and zinc balance during acute gastroenteritis in infants.

C Castillo-Durán1, P Vial, R Uauy.   

Abstract

To evaluate the effect of copper supplementation during recovery from acute diarrhea, we randomly assigned 14 hospitalized infants to receive either 80 micrograms copper sulfate.kg body wt-1.d-1 or a placebo. Metabolic balance and plasma copper and zinc concentrations were measured before randomization (period 1) and 6 d after admission (period 2). Fifteen control subjects were studied after respiratory illness. Fecal copper was not affected by supplementation; fecal zinc during period 2 rose significantly only in the copper-supplemented group. Copper retention was significantly higher in the supplemented infants; plasma concentrations increased for period 2 but were similar to those in the placebo group. Zinc concentrations improved over time in both groups but zinc retention was higher in the placebo group for period 2. A significant interference by copper supplementation on zinc absorption was noted. Copper supplementation during the early phase of recovery from diarrhea is not recommended.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2349923     DOI: 10.1093/ajcn/51.6.1088

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  3 in total

1.  Zinc and copper in infants fed breast-milk or different formula.

Authors:  I Lombeck; A Fuchs
Journal:  Eur J Pediatr       Date:  1994-10       Impact factor: 3.183

2.  Functional and Genetic Characterization of Porcine Beige Adipocytes.

Authors:  Lilan Zhang; Silu Hu; Chunwei Cao; Chuanhe Chen; Jiali Liu; Yu Wang; Jianfeng Liu; Jianguo Zhao; Cong Tao; Yanfang Wang
Journal:  Cells       Date:  2022-02-21       Impact factor: 6.600

3.  Zinc and copper supplementation in acute diarrhea in children: a double-blind randomized controlled trial.

Authors:  Archana Patel; Michael J Dibley; Manju Mamtani; Neetu Badhoniya; Hemant Kulkarni
Journal:  BMC Med       Date:  2009-05-05       Impact factor: 8.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.